Last reviewed · How we verify
NCT04262011
Effect of Non-surgical Periodontal Treatment and C-reactive Protein Levels in Hemodialysis Patients
NA trial testing immediate treatment in Chronic Kidney Disease Stage 5 in 88 participants. Status unknown.
1 November 2020
Quick facts
| Lead sponsor | Universidade Federal de Santa Maria |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 88 |
| Start date | 29 February 2020 |
| Primary completion | 1 November 2020 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- immediate treatment
- postponed treatment
Conditions studied
- Chronic Kidney Disease Stage 5 — all drugs for Chronic Kidney Disease Stage 5 →
- Periodontitis — all drugs for Periodontitis →
Sponsor
Universidade Federal de Santa Maria — full company profile →
Who can join
Adults 18 to 90, any sex, with Chronic Kidney Disease Stage 5 or Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The presence of periodontitis has been hypothesized as a risk factor for several systemic outcomes, including chronic kidney disease (CKD). Therefore, the aim of this study is to evaluate the impact of non-surgical periodontal treatment on CRP levels and quality of life of patients with chronic kidney disease undergoing hemodialysis (HD) in Santa Maria-RS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04262011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Disease Stage 5
Currently open trials in the same condition.
- NCT06982079 — Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease · Phase 3 · recruiting
- NCT06799936 — A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinic · NA · recruiting
- NCT06542016 — An Evaluation of the KCCQ Score in Predicting Cardiovascular Risk in Dialysis Patients · recruiting
- NCT05726526 — CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients · NA · recruiting
Other Universidade Federal de Santa Maria trials
Trials by the same sponsor.
- NCT07584460 — Juçara (Euterpe Edulis Martius) Supplementation Effect in Muscle Protection, Performance and Soreness in Lower Limbs Aft · NA · completed
- NCT05948722 — Behavioral Intervention Program Based on Motivational Interview · NA · active not recruiting
- NCT06371287 — Effect of Musical Auditory Training on Subjects With Tinnitus Disorder · NA · recruiting
- NCT04418700 — Effects of the Breath Stacking Technique After Upper Abdominal Surgery · NA · completed
- NCT04273971 — Acute Effect of Plyometric Exercises on Musculotendinous Properties · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04262011 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Santa Maria
- Last refreshed: 20 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04262011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing